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Abstract  
Objective: To evaluate the effect of a dialogue-based intervention targeting psychosocial 
well-being at 12 months post-stroke. 
Design: Multicenter, prospective, randomized, assessor-blinded, controlled trial with two 
parallel groups. 
Setting: Community. 
Subjects: Three-hundred and twenty-two adults (≥ 18 years) with stroke within the last 4 
weeks were randomly allocated into intervention group (n=166) or control group (n=156). 
Interventions: The intervention group received a dialogue-based intervention to promote 
psychosocial well-being, comprising eight individual 1-1 ½ hour sessions delivered during 
the first 6 months post-stroke.  
Main measures: The primary outcome measure was the General Health Questionnaire-28 
(GHQ-28). Secondary outcome measures included the Stroke and Aphasia Quality of Life 
Scale-39g, the Sense of Coherence scale and the Yale Brown single item questionnaire.  
Results: The mean (SD) age of the participants were 66.8 (12.1) years in the intervention 
group and 65.7 (13.3) years in the control group. At 12 months post-stroke, the mean (SD) 
GHQ-28 score was 20.6 (0.84) in the intervention group and 19.9 (0.85) in the control group. 
There were no between-group differences in psychosocial well-being at 12 months post-
stroke (mean difference -0.74, 95% CI: -3.08, 1.60). The secondary outcomes showed no 
statistically significant between-group difference in health-related quality of life, sense of 
coherence, or depression at 12 months. 
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Conclusion: The results of this trial did not demonstrate lower levels of emotional distress 
and anxiety or higher levels of health-related quality of life in the intervention group 
(dialogue-based intervention) as compared to the control group (usual care) at 12 months 
post-stroke.  
Keywords: Stroke, Rehabilitation, Randomized Controlled Trial, Sense of Coherence, 
Psychosocial Support Systems 
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Introduction 
Stroke is one of the leading causes of death and disability in the adult population worldwide.1 
It may have a devastating effect on people, not only physically, but also emotionally, 
therefore it is not surprising that psychosocial well-being may be threatened following stroke. 
Depressive symptoms, anxiety, general psychological distress, and social isolation are 
prevalent.2, 3 About one-third of stroke survivors report depressive symptoms, and 20% report 
anxiety post-stroke.4, 5 Psychosocial problems persist over time, and the prevalence of post-
stroke depression remains high at 25% in the period from 1 to 5 years post-stroke.4 
Psychosocial difficulties may significantly impact long-term functioning and quality of life,6, 
7 reduce the effects of rehabilitation services, and lead to higher mortality.8  
Despite inconclusive evidence,9, 10 targeted treatments to promote psychosocial 
adjustment may improve psychosocial well-being.6, 11 In our work, psychosocial well-being 
was defined as consisting of a basic mood of contentment, a self-concept characterized by 
self-acceptance, usefulness and a belief in one’s abilities. Having social relationships and 
support, a feeling of loving and being loved in relationships are included in the definition, as 
well as participation and engagement in meaningful activities beyond oneself.12, 13 The 
feasibility work preceding this randomized controlled trial (RCT) suggested that it is possible 
to promote psychosocial well-being and coping through a dialogue-based intervention.13-15 
We hypothesized that a dialogue-based intervention would lead to higher levels of 
psychosocial well-being expressed through lower levels of emotional distress and anxiety at 
12 months post-stroke. Secondary hypotheses were that stroke survivors who received the 
intervention would experience significantly higher levels of health-related quality of life and 
sense of coherence at 12 months post-stroke. 
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Methods 
In this study, patient enrolment started in November 2014 and concluded data collection in 
November 2017. The Regional Committee for Medical and Health Research Ethics, South-
East (REC no. 2013/2047) and the Data Protection Officer serving all participating hospitals 
(Case number: 2014/1026) approved the study. Written informed consent was obtained from 
all participants. Due to strict regulations and conditions for informed consent enforced by 
Norwegian law, the data set that support the findings of this study is not publicly available. A 
subset of the data may be made available from the corresponding author upon reasonable 
request. The study was registered with ClinicalTrials.gov (NCT02338869), and the study 
protocol outlining the full details of the study was published in BMC Psychology in 2018. 15  
The study was a multicenter, prospective, randomized, assessor-blinded, controlled 
trial with 2 parallel groups (intervention and standard stroke treatment) and an equal size 
allocation ratio of 1:1. Eleven hospitals with stroke units or rehabilitation centers in South-
Eastern Norway enrolled patients. Eligible participants were adults aged ≥ 18 years, had 
suffered an acute stroke within the last 4 weeks, were medically stable, had sufficient 
cognitive functioning to participate, were able to understand and speak Norwegian before 
stroke onset, and were able to give informed consent. Exclusion criteria were moderate to 
severe dementia or other serious physical or psychiatric diseases, and severe receptive or 
expressive aphasia.  
The sample size was determined based on the primary outcome measure General 
Health Questionnaire-28 (GHQ-28). The calculations were based on a repeated measures 
logistic regression model of the binary output variable “normal mood” (GHQ-28 <5) with 2 
measurements for each patient (i.e., one at 6 months and one at 12 months).15 Based on the 
results of comparable studies,11, 16 we deemed an odds ratio of 1.6 or higher between-groups 
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(intervention/control) with normal mood after 6 and 12 months to be clinically relevant. With 
80% power across both time points and a significance level α at 0.05, the sample size was 
estimated to 300 patients (150 per group), which was inflated to a total of 330 to allow for a 
potential 10% drop-out.15 
A computer-generated block randomization procedure with blocks of 10 stratified by 
hospital and with an allocation ratio of 5:5, was used in this study. An assistant independent 
of the research team, prepared opaque randomization envelopes. Two regional trial 
coordinators carried out the allocation following the baseline assessment. Participants were 
informed about group allocation immediately. To ensure masking of group allocation at the 
follow-up assessments a message was issued from the trial coordinators to participants with a 
reminder not to reveal their group allocations to the assessors. 
The primary and secondary outcomes and measures are presented in Table 1. The 
primary outcome was psychosocial well-being at 12 months post-stroke. The GHQ-28 
measures symptoms of emotional distress.17, 18 In light of the extensive literature of the high 
prevalence of emotional distress following stroke, we assumed that well-being in this 
population would premise the absence of emotional distress. Consequently, in this study we 
operationalized psychosocial well-being as lower levels of emotional distress and used the 
GHQ-28 to measure it. For additional details on the scoring of the GHQ-28 in this study, 
please refer to the online supplementary material (Supplemental file 1). Clinical 
characteristics such as stroke classification, side localization of the stroke symptoms, stroke 
severity, cognitive function, and language difficulties were assessed at the hospital and were 
collected from the patients’ medical records. 
[Insert Table 1] 
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Data were collected in-person via structured interviews conducted by trained health 
care professionals (registered nurses and occupational therapists) at baseline, 4-6 weeks post-
stroke (T1), and at 6 (T2) and 12 (T3) months post-stroke. The data collectors were blinded 
to group allocation. The participants’ ages, sexes, living situations, caring responsibilities, 
previous illnesses and comorbidities, and current rehabilitation services were recorded in 
addition to the structured outcome measures.  
All participants randomized into the study received standard stroke treatment in the 
acute phase according to the Norwegian stroke treatment guideline.19 In Norway, patients 
with minor stroke are typically discharged home with access to interdisciplinary 
rehabilitation services in the municipality according to need and availability of the service. 
Services typically include physical therapy and/or occupational therapy and/or speech and 
language therapy and/or home nursing care. Systematic psychosocial follow up is rarely part 
of the services provided.  Patients with severe stroke are typically discharged to a specialized, 
in-patient rehabilitation unit for specialized rehabilitation services.  
Participants randomized to the intervention group were offered a dialogue-based 
intervention to promote psychosocial well-being. The intervention consisted of 8 individual 
1-1 ½-hour sessions between the participants and a specially trained nurse or occupational 
therapist (intervention providers). The intervention providers completed a three-day training 
program to learn how to guide the sessions and how to work with the participants based on 
the principles outlined in the protocol.15 The intervention was delivered in the community, 
primarily in the participants’ homes. The same intervention provider worked with each 
participant in all sessions.  
In line with the protocol,15 the intervention started shortly after randomization; 4 to 8 
weeks after stroke onset. It lasted 17 weeks, and the last session was completed within 6 
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months post-stroke.15, 20 A guide of stroke-related topics and work-sheets for each session 
were supplied as part of the intervention.15 The intervention provider and the participant were 
encouraged to individually adapt the order of topics and the time in-between sessions to suit 
the needs of the participants. Additional details on theoretical perspectives underpinning the 
intervention, themes, and content of the intervention are outlined in the protocol.15 
 Implementation fidelity was assessed and previously published as part of the process 
evaluation of this RCT.20 The assessment of implementation fidelity included a separate 
analysis of intervention adherence. The composite adherence score showed that 117 (80.1%) 
of the intervention trajectories satisfied the criteria for high fidelity intervention adherence.20  
 
Statistical Analysis 
The data were analyzed using an intention-to-treat approach. Missing data were imputed 
using multiple imputation by chained equations in the Statistical Package for the Social 
Sciences (SPSS). 21, 22 All reported results of the statistical analyses were pooled across 5 
imputations based on Rubin’s rule 23. The statistical software R v3.6.1 24 with package 
mitools v2.4 was used to pool the results across all 5 imputed data sets. For additional details 
of the imputation model, please see the online supplementary material (Supplemental file 2). 
Analyses of the primary and secondary outcomes were performed using logistic 
regression for binary outcomes and independent and paired samples t-tests for continuous 
outcomes. A linear mixed model was used to assess the primary outcome of psychosocial 
well-being at 12 months post-stroke. Due to the complexity of the final model, we did not use 
the dichotomized “normal mood” (GHQ-28 < 5) endpoint, as it resulted in convergence 
issues when fitting the binary logistic mixed model. The continuous sum-score based on the 
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Likert-scoring of GHQ-28 was used as the dependent variable. The other factors of the model 
remained the same as in the predetermined statistical analysis plan. The details of the linear 
mixed model are supplied in the online supplementary files (Supplemental file 3). 
 Statistical tests were performed with SPSS, version 25.0 for Windows.25 All 
statistical tests were performed as two-sided tests with a significance level of α =0.05. 
 
Results 
The CONSORT flow diagram is presented in Figure 1. Three-hundred-and fifty-three 
(58.2%) of the eligible individuals consented to participate in this study. There were no 
significant differences in age and sex between individuals who consented and those who did 
not.26 Between consent and the baseline assessment 31 (8.8%) participants dropped out. 
Thus, 322 participants were assessed at baseline and subsequently allocated to the 
intervention group (n=166) or the control group (n=156).  
[Insert Figure 1] 
Baseline demographics and clinical characteristics are presented in Table 2, and it 
shows that the characteristics were similar in both groups except for self-reported depression 
and stroke classification (infarction or hemorrhage).  
[Insert Table 2] 
Results from the between-group comparisons at 12 months post-stroke for primary 
and secondary outcomes are presented in Table 3. There were no between-group differences 
in psychosocial well-being at 12 months post-stroke (mean difference -0.74, 95% CI: -3.08, 
1.60).  
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The secondary outcomes showed no statistically significant between-group difference 
in depression, sense of coherence, or health-related quality of life at 12 months (Table 3). 
Self-reported depression showed no between-group difference at 12 months (OR 0.96, 95% 
CI: 0.55, 1.68). Sense of coherence scores appeared to be stable in both groups throughout 
the study trajectory. The overall health-related quality of life improved across the trajectory, 
but there was no statistically significant difference between the intervention and control 
groups at 12 months (mean difference 0.06, 95% CI: -0.04, 0.17) (Table 3).  
 [Insert Table 3] 
The results of the linear mixed model analysis are displayed in table 4. This analysis 
showed that the fixed effect of time was negative for both 6 months and 12 months, which 
implies a reduced GHQ-28 score overall compared to the baseline, indicating a higher level 
of psychosocial well-being at 6 months and 12 months post-stroke relative to the baseline 
(Table 4). Additionally, 5 other explanatory variables had statistically significant fixed effects 
influencing the GHQ-28 scores.  
Higher scores on sense of coherence were associated with lower GHQ-28 scores, 
indicating that higher sense of coherence scores were associated with higher levels of 
psychosocial well-being. Reporting additional comorbidities, caring responsibilities, fatigue, 
and depression was associated with higher GHQ-28 scores, which indicated lower 
psychosocial well-being. Adjusted for all factors in the linear mixed model, the intervention 
group scored lower (mean difference: -0.96 points, 95% CI: -2.18, 0.26) on GHQ-28 
compared to the control group, however, the between-group differences were not statistically 
significant (Table 4).  
[Insert Table 4] 
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Discussion 
Contrary to our hypotheses, the results of this trial did not demonstrate at the specified 
statistical significance level that the participants in the intervention group experienced higher 
levels of psychosocial well-being and lower levels of depressive symptoms and anxiety than 
participants in the control group at 12 months post-stroke. Nor did the secondary outcomes 
show statistically significantly higher levels of sense of coherence or higher levels of health-
related quality of life in the intervention group compared with the control group at 12 months 
post-stroke.  
In the following, we will highlight possible reasons for the statistically non-significant 
results in this RCT, drawing on the results of a comprehensive process evaluation of the RCT 
and existing research to interpret the outcomes of the trial.20, 27 Plausible explanations may 
include flaws in the underlying theoretical assumptions or characteristics of the intervention, 
the timing of the intervention, the standard care provided to the intervention and control 
groups, the sample of participants enrolled, or the outcome measures.  
Based on Antonovsky’s theory of sense of coherence,28 we assumed that an important 
active ingredient in the intervention would be to support the participants’ perceptions of their 
lives as comprehensible, manageable, and meaningful. We anticipated that the intervention 
would foster understanding and re-creation of meaning through narrative dialogue, and that 
the intervention provider could support the participants’ coping efforts and development of 
new life skills through the guided self-determination problem-solving approach.13, 14  
Antonovsky framed sense of coherence as a stable trait that may to some degree be 
dynamic with fluctuations in periods of threatening life events.28 Others have shown that 
sense of coherence is less stable over time than Antonovsky assumed.29 We hypothesized that 
the intervention would be able to influence the participants’ sense of coherence after a life-
13 
 
threatening event such as stroke, and that a higher sense of coherence would lead to higher 
levels of psychosocial well-being.  
This twofold hypothesis was only supported in part. The lack of differences within 
groups over time and between the intervention and control group does not support the notion 
that the intervention succeeded in influencing the levels of sense of coherence. The results of 
the study suggest that this intervention did not influence sense of coherence and that it is a 
stable construct. However, the results support the notion that a higher sense of coherence is 
important in the promotion of psychosocial well-being.  
This knowledge may be important to clinicians who need to be able to identify stroke 
patients who need extra attention with regards to promoting psychosocial well-being. It may 
be advisable to screen for sense of coherence during the early post-stroke phase to identify 
those with lower sense of coherence, who may be more vulnerable to lower psychosocial 
well-being.  
Another assumption made in this intervention was that it would be possible to prevent 
depression that manifested after stroke due to the increased stress and chaos of trying to cope 
with the post-stroke changes.3 For some participants the intervention may have led to 
decreasing stress and for some to potentially increasing it, depending on their existing stress 
levels. If the participants did not experience increased stress or challenges in coping in this 
phase of their adjustment process, we need to consider if the focus on psychosocial 
challenges in the intervention may have increased rather than decreased their stress. In the 
future, screening for distress at baseline may be advisable in order to explore whether the 
intervention may be more appropriate for those with some level of existing stress/distress. 
Based on assumptions that early rehabilitation efforts are important to promote 
psychosocial well-being,3, 13 the intervention in this trial was designed to be delivered over a 
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period of 5 months starting 4-6 weeks post-stroke and concluding within 6 months post-
stroke.13, 15  The intervention period coincides with a period in which spontaneous functional 
recovery may peak, 30, 31 and overlaps with a period of comprehensive physical rehabilitation 
within Norwegian stroke services.19 The psychosocial intervention provided to the 
intervention group may not have made a discernable impact in this context with substantial 
rehabilitation efforts within the regular health care services.  
At baseline, participants in both groups reported high scores on the Stroke and 
Aphasia Quality of Life Scale-39g (Table 3). Though these scores may seem to imply ceiling 
effects suggesting limited room for improvement, the minimally important difference on the 
Stroke and Aphasia Quality of Life Scale-39g has been reported as 0.21.32 Therefore, despite 
high baseline scores there was still room for improvement in health-related quality of life in 
this group of participants.  
The participants received substantial rehabilitation services as part of their standard 
stroke treatment. At baseline, 114 (68.7%) participants in the intervention group and 99 
(63.5%) participants in the control group received one or more rehabilitation services, most 
frequently physical therapy. At 12 months the proportion was still high; 70 (42.3%) 
participants in the intervention group and 66 (42.1%) participants in the control group.  
Earlier theoretical work has shown that the physical recovery, daily life adaptation, 
and normalization, as well as biographical adjustment, occurs simultaneously throughout the 
first 12 months of the adjustment process after a stroke.31 However, the focus on physical 
recovery is more pronounced in the beginning, while the focus on psychosocial issues such as 
biographical adjustment gains emphasis later in the trajectory. Introducing this intervention 
on top of the natural recovery and rehabilitation processes may not have added to the 
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adjustment process, or the participants may have been more focused on other parts of their 
adjustment than that of a psychosocial nature.  
It is important to consider whether the extra attention given to the psychosocial issues 
in the intervention group came at an inappropriate time in the participants’ stroke recovery 
and whether we may have increased the awareness on psychosocial difficulties rather than 
prevented them. Other studies have shown successful results in promoting normal moods 
when introducing early psychosocial support by providing motivational interviewing to 
support and build patients’ motivation to adjust and adapt to having had a stroke.11  
In the study of Watkins et al,11, 16 motivational interviewing aimed to promote self-
efficacy. The patients raised the issues they wanted to discuss themselves instead of having 
topics outlined for each meeting.16 Compared to the theoretical assumptions of anticipated 
active ingredients of the intervention tested in this RCT, motivational interviewing may have 
been more aligned with the patients’ phase of adjustment and more aligned with their focus 
on i.e. getting well or frustration in this early adjustment phase.33 The focus on patient-
initiated discussion themes rather than the pre-specified themes related to psychosocial issues 
may have supported their adjustment to a greater degree than in the intervention tested in this 
RCT. 
The feasibility work done during the development of the intervention showed that 
participants found the intervention helpful, however, it failed to clearly identify specific 
patient groups who would potentially benefit from this intervention.13, 14, 34, 35  Wide inclusion 
criteria were applied in the RCT, which may have inadvertently resulted in the enrolment of 
participants who did not particularly need this kind of intervention. The process evaluation 
that was conducted alongside the trial showed that not all participants expected a personal 
benefit and that a key motivation to participate was to contribute to research and to help other 
stroke survivors.27 Despite this observation, the majority of the participants who participated 
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in the qualitative interviews as part of the process evaluation found the intervention useful 
and found that it facilitated their post-stroke adjustments.27  
Some participants in the control group reported that the assessment interviews 
facilitated reflection and adjustment, and some indicated that allocation to the control group 
and the themes raised in the assessment interviews influenced their help-seeking behavior 
outside the trial.36  
It is still important to identify sub-groups of the stroke population who might benefit 
from a psychosocial intervention to promote psychosocial well-being. Patients who reported 
depressive symptoms, fatigue, comorbidities and caring responsibilities were prone to lower 
levels of psychosocial well-being in this study. Earlier studies have shown that emotional 
distress at 1 month post-stroke, higher stroke severity, and communication impairments 
predict emotional distress during the first 6 months post-stroke.37  
Studies exploring predictors of emotional distress and well-being in a longer post-
stroke perspective have found that higher age (> 65), independence in mobility, having social 
support, and being employed are important predictors of well-being.38 Conversely 
dependency in activities of daily living (i.e., toileting) predict emotional distress 2-5 years 
post-stroke.38 Identifying patients with the characteristics identified in this and other studies 
may be especially important in clinical settings to identify those who may need closer 
attention and follow-up with regards to psychosocial well-being.  
 There is a need to consider whether the chosen outcome measures were appropriate to 
detect the kind of change the intervention targeted. The change in emotional distress in both 
the intervention and control groups across the trajectory indicated that the GHQ-28 was 
sensitive to change. There was a substantial increase in the proportion of participants with 
GHQ-28 scores < 5 in both groups. Furthermore, the level of improvement exceeded the 
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findings in a similar study in which motivational interviewing was provided post-stroke.11, 16 
However, the sensitivity of the GHQ-28 does not necessarily mean it was the most suitable 
outcome measure in this study.  
The intervention was aimed at promoting psychosocial well-being. Thus, using an 
instrument that measured breaks in normal function and presence of emotional distress and 
reduction in depressive symptoms to enable comparison with similar studies may not have 
been an ideal choice. Including a measure that targeted the positive concept of well-being 
more directly, such as the Warwick-Edinburgh Mental Wellbeing Scales, could have 
strengthened the study. This scale was developed to enable the measuring of mental well-
being in the general population and to enable the evaluation of interventions that aim to 
improve mental well-being.39  
Based on the definition of psychosocial well-being used in the development of this 
intervention, including outcome measures that assess participation in meaningful activities 
may have added important data to evaluate the outcomes of the intervention. The lack of such 
an outcome measure was a limitation to this study. Additional outcome measures for 
participation and well-being should be explored in future research.  
 A strength in this study was the systematic development and feasibility testing of the 
intervention prior to full scale effectiveness tests in this RCT.13, 14 The trial was conducted in 
a rigorous manner following the Consolidated Standards of Reporting Trials (CONSORT) 
statement.40  
Additionally, the comprehensive process evaluation, including the evaluation of 
implementation fidelity that was conducted alongside the trial,20 was an important advantage 
in documenting the trial implementation and in understanding trial outcomes.  
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All intervention providers and assessors participating in the study were required to 
complete training prior to their participation, which was important in establishing uniform 
delivery of the intervention and the assessment interviews. Completing intervention sessions 
with parallel goals of individualization and uniform delivery may, however, have been a 
limitation in this study. Participating in supervision sessions was voluntary for intervention 
providers, and the follow-ups of the assessors was also based on a voluntary and as-needed 
basis. In retrospect, mandatory follow-up and supervision may have been warranted to assure 
uniform delivery of the intervention and uniform assessment across the study trajectory.  
Another limitation in this study was the difficulties in enrolling patients with more 
severe stroke symptoms and aphasia who were presumably more vulnerable to psychosocial 
problems. However, the sample included in this study represents the largest group of stroke 
patients admitted to hospitals in Norway.26  The nurses and occupational therapists who 
enrolled participants reported that it was difficult to assess whether patients with aphasia 
were able to consent. Ensuring an informed consent was perceived to be too time-consuming 
in the clinical setting, resulting in few participants with aphasia.  
Furthermore, enrolment personnel found it difficult to approach the patients with 
more severe stroke during the short time that they were treated in the stroke unit. These 
challenges emphasized the need for dedicated personnel that were not involved in other 
clinical duties while simultaneously enrolling patients to the trial. For future studies, it may 
be advisable to enroll patients directly from the community and from rehabilitation units 
providing sub-acute care to reach a broader group of patients with more severe impairments. 
This study showed that certain sub-groups (patients reporting depressive symptoms, 
fatigue, comorbidities, and caring responsibilities) were prone to lower levels of psychosocial 
well-being. The results also support the notion that a higher sense of coherence is important 
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in the promotion of psychosocial well-being. This may inform inclusion criteria and 
screening for certain vulnerabilities when enrolling participants in future research.  
 The results in this study suggest that more research is needed to explore the 
relationships between psychosocial well-being, sense of coherence and the process of 
meaning-making and adjustment following an acute stroke. Additional mechanisms, such as 
the impact of resilience should be taken into account. Furthermore, exploring these 
relationships must include the use of more adequate instruments to measure psychosocial 
well-being.    
With respect to clinical practice, there is insufficient evidence to support the 
implementation of the intervention in its current form based on the outcome measures used in 
this RCT. However, the inclusion criteria in this study may have been too wide, and further 
research is needed to confirm whether certain sub-groups of stroke patients may benefit from 
such a psychosocial intervention and at what time post-stroke such an intervention may be 
appropriate. 
 
Clinical messages  
• The dialogue-based intervention implemented in this RCT did not lead to lower levels 
of emotional distress and anxiety at 12 months post-stroke. 
• The intervention did not lead to higher levels of health-related quality of life or higher 
sense of coherence at 12 months post-stroke. 
• Based on the outcome measures used in this study, there is insufficient evidence to 
support implementation of the intervention in its current form. 
 
20 
 
Acknowledgements  
We acknowledge the patients for their valuable participation in the trial. We acknowledge all 
the nurses and occupational therapists who conducted the interventions and the assessment 
interviews, and we acknowledge the institutions which facilitated study activities. We also 
acknowledge all participating centers of the RCT for granting access to participants and 
especially the recruitment personnel for their efforts in enrolling participants into the trial. 
 
Declaration of Conflicting Interests 
The authors declare that there are no conflicts of interest. 
 
Sources of Funding 
The authors disclosed receipt of the following financial support for the research, authorship, 
and/or publication of this article: the European Union Seventh Framework Programme (FP7-
PEOPLE-2013-COFUND) [grant agreement no 609020 - Scientia Fellows]; the South-
Eastern Norway Regional Health Authority [Project no 2013086]; and the Extra Foundation 
[grant number 2015/FO13753]. The University of Oslo, Oslo University Hospital, the Inland 
Norway University of Applied Sciences, and UiT, the Arctic University of Norway, Narvik 
have provided research time, administrative and organizational support and additional 
funding for the study.   
 
Trial registration 
Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: 
NCT02338869. Date of registration: 10/4/2014.  
21 
 
References 
1. Feigin VL, Roth GA, Naghavi M, et al. Global burden of stroke and risk factors in 188 
countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 
2013. Lancet Neurol 2016; 15: 913-924.  
2. Kouwenhoven S, Kirkevold M, Engedal K, et al. Depression in acute stroke: prevalence, 
dominant symptoms and associated factors. A systematic literature review. Disabil Rehabil 
2011; 33: 539-556.  
3. Whyte EM and Mulsant BH. Post Stroke Depression: Epidemiology, Pathophysiology, and 
Biological Treatment. Biol Psychiatry 2002; 52: 253-264.  
4. Hackett ML and Pickles K. Part I: frequency of depression after stroke: an updated systematic 
review and meta-analysis of observational studies. Int J Stroke 2014; 9: 1017-1025.  
5. Campbell Burton C, Murray J, Holmes J, et al. Frequency of anxiety after stroke: A 
systematic review and meta-analysis of observational studies. Int J Stroke 2013; 8: 545-559.  
6. Teoh V, Sims J and Milgrom J. Psychological Predictors of Quality of Life in a Sample of 
Community-Dwelling Stroke Survivors: A Longitudinal Study. Top Stroke Rehabil 2009; 16: 
157-166. 
7. Ferro JM, Caeiro L and Santos C. Poststroke emotional and behavior impairment: a narrative 
review. Cerebrovasc Dis 2009; 27 Suppl 1: 197-203.  
8. Bartoli F, Lillia N, Lax A, et al. Depression after stroke and risk of mortality: a systematic 
review and meta-analysis. Stroke Res Treat 2013; 2013: 862978.  
9. Hackett ML, Anderson CS, House A, et al. Interventions for preventing depression after 
stroke. Cochrane Database Syst Rev 2008: CD003689.  
10. Hackett ML, Anderson CS, House A, et al. Interventions for treating depression after stroke. 
Cochrane Database Syst Rev 2008: CD003437.  
11. Watkins CL, Wathan JV, Leathley MJ, et al. The 12-month effects of early motivational 
interviewing after acute stroke: a randomized controlled trial. Stroke 2011; 42: 1956-1961.   
12. Næss S. Livskvalitet som psykisk velvære. [Quality of life as psychological well-being]. 
Tidsskr Nor Laegeforen [Journal of Norwegian Medical Association] 2001; 121: 1940-1944. 
13. Kirkevold M, Bronken BA, Martinsen R, et al. Promoting psychosocial well-being following 
a stroke: developing a theoretically and empirically sound complex intervention. Int J Nurs 
Stud 2012; 49: 386-397.  
14. Kirkevold M, Martinsen R, Bronken BA, et al. Promoting psychosocial wellbeing following 
stroke using narratives and guided self-determination: a feasibility study. BMC Psychol 2014; 
2: 4.  
15. Kirkevold M, Bragstad LK, Bronken BA, et al. Promoting psychosocial well-being following 
stroke: study protocol for a randomized, controlled trial. BMC Psychol 2018; 6: 12.  
16. Watkins CL, Auton MF, Deans CF, et al. Motivational interviewing early after acute stroke: a 
randomized, controlled trial. Stroke 2007; 38: 1004-1009.  
17. Goldberg DP and Hillier VF. A scaled version of the General Health Questionnaire. Psychol 
Med 1979; 9: 139-145.  
18. Malt U, Mogstad T and Refnin I. Goldbergs General Health Questionnaire Tidskr Nor 
Lægeforen [Journal of Norwegian Medical Association] 1989; 109: 1391-1394. 
19. Norwegian Directorate of Health. Treatment and Rehabilitation After Stroke (Clinical 
Guideline). Norway. 2018. 
22 
 
20. Bragstad LK, Bronken BA, Sveen U, et al. Implementation fidelity in a complex intervention 
promoting psychosocial well-being following stroke: an explanatory sequential mixed 
methods study. BMC Med Res Methodol 2019; 19: 59 
21. White IR, Royston P and Wood AM. Multiple imputation using chained equations: Issues and 
guidance for practice. Stat Med 2011; 30: 377-399.  
22. Plumpton CO, Morris T, Hughes DA, et al. Multiple imputation of multiple multi-item scales 
when a full imputation model is infeasible. BMC Res Notes 2016; 9: 45.  
23. Rubin D. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley and Sons, 
2004. 
24. R Core Team. R: A language and environment for statistical computing. Vienna, Austria.: R 
Foundation for Statistical Computing, 2019. 
25. IBM Corp. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp., 2017. 
26. Hjelle EG, Bragstad LK, Kirkevold M, et al. Effect of a dialogue-based intervention on 
psychosocial well-being 6 months after stroke in Norway: A randomized controlled trial. J 
Rehabil Med 2019; 51: 557-565.  
27. Kitzmuller G, Mangset M, Evju AS, et al. Finding the Way Forward: The Lived Experience 
of People With Stroke After Participation in a Complex Psychosocial Intervention. Qual 
Health Res 2019: 1049732319833366.  
28. Antonovsky A. Unravelling the mystery of health. How people manage stress and stay well. 
San Francisco: Jossey-Bass, 1987. 
29. Eriksson M and Lindstrom B. Validity of Antonovsky's sense of coherence scale: a systematic 
review. J Epidemiol Community Health 2005; 59: 460-466.  
30. Cassidy JM and Cramer SC. Spontaneous and Therapeutic-Induced Mechanisms of 
Functional Recovery After Stroke. Transl Stroke Res 2017; 8: 33-46.  
31. Kirkevold M. The role of nursing in the rehabilitation of stroke survivors: an extended 
theoretical account. ANS Adv Nurs Sci 2010; 33: E27-40.  
32. Guo YE, Togher L, Power E, et al. Sensitivity to change and responsiveness of the Stroke and 
Aphasia Quality-of-Life Scale (SAQOL) in a Singapore stroke population. Aphasiology 2017; 
31: 427-446. 
33. Auton MF, Patel K, Carter B, et al. Motivational Interviewing Post-Stroke: An Analysis of 
Stroke Survivors' Concerns and Adjustment. Qual Health Res 2016; 26: 264-272.  
34. Martinsen R, Kirkevold M, Bronken BA, et al. Work-aged stroke survivors' psychosocial 
challenges narrated during and after participating in a dialogue-based psychosocial 
intervention: a feasibility study. BMC nurs 2013; 12: 22.  
35. Bronken BA, Kirkevold M, Martinsen R, et al. Psychosocial well-being in persons with 
aphasia participating in a nursing intervention after stroke. Nurs Res Pract 2012; 2012: 
568242.  
36. Mangset M, Kitzmuller G, Evju AS, et al. Psychosocial well-being after stroke - control group 
participants’ experiences of their participation in an RCT. Trials [Pending publication]. 
37. Thomas SA and Lincoln NB. Predictors of Emotional Distress After Stroke. Stroke 2008; 39: 
1240-1245.  
38. Bergersen H, Schanke A-K and Sunnerhagen KS. Predictors of Emotional Distress and 
Wellbeing 2-5 Years After Stroke. ISRN Stroke 2013; 2013: 7.  
39. Tennant R, Hiller L, Fishwick R, et al. The Warwick-Edinburgh Mental Well-being Scale 
(WEMWBS): development and UK validation. Health Qual Life Outcomes 2007; 5: 63.  
23 
 
40. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: 
updated guidelines for reporting parallel group randomised trials. Int J Surg 2012; 10: 28-55.  
41. Hilari K, Lamping DL, Smith SC, et al. Psychometric Properties of the Stroke and Aphasia 
Quality of Life Scale (Saqol-39) in a Generic Stroke Population. Clin Rehabil 2009; 23: 544-
557.  
42. Hilari K, Byng S, Lamping DL, et al. Stroke and Aphasia Quality of Life Scale-39 (Saqol-
39): Evaluation of Acceptability, Reliability, and Validity. Stroke 2003; 34: 1944-1950.  
43. Watkins CL, Lightbody CE, Sutton CJ, et al. Evaluation of a single-item screening tool for 
depression after stroke: a cohort study. Clin Rehabil 2007; 21: 846-852.  
44. Mahoney J, Drinka T, Abler R, et al. Screening for Depression: Single Question versus GDS. 
J Am Geriatr Soc 1994; 9: 1006-1008.  
45. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom 
Res 1993; 37: 147-153.  
46. Loge JH, Ekeberg O and Kaasa S. Fatigue in the general Norwegian population: normative 
data and associations. J Psychosom Res 1998; 45: 53-65.  
47. Thommessen B, Thoresen G, Bautz-Holter E, et al. Screening by nurses for aphasia in stroke - 
the Ullevaal Aphasia Screening (UAS) test. Disabil Rehabil 1999; 21: 110-115.  
48. Fure B, Bruun Wyller T, Engedal K, et al. Cognitive impairments in acute lacunar stroke. 
Acta Neurol Scand 2006; 114: 17-22.  
49. Brott T, Adams H and Olinger C. Measurements of acute cerebral infarction: a clinical 
examination scale Stroke 1989; 20: 964–970.  
50. Folstein MF, Folstein SE and McHugh PR. "Mini-mental state". A practical method for 
grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.  
 
 
  
24 
 
Tables 
1. Outcomes and measures with scoring and time of assessment. 
2. Baseline demographics and clinical characteristics 
3. Primary and secondary outcomes with between-group differences at 12-month follow 
up, by group 
4. Linear mixed model showing fixed effect coefficients 
Figures 
1. CONSORT participant recruitment and retention flow chart 
Online Supplement 
1. Scoring of GHQ-28  
2. Imputation model (multiple imputation by chained equations) 
3. Linear mixed model with random and fixed effects (syntax) 
4. CONSORT checklist 
25 
 
Table 1: Outcomes and measures with scoring and time of assessment. 
 
1 T0=Data from acute phase collected from patient record, T1=Baseline assessment at 4-6 weeks post-stroke, T2=Assessment at 6 months post-stroke, T3=Assessment at 12 
months post-stroke 
Primary 
outcome 
Measure Description 
Scoring  
Assessment1 
Psychosocial 
well-being 
 
The General Health 
Questionnaire-28 (GHQ-28) 
17, 18 
Scaled 28-item self-report questionnaire measuring 
emotional distress. Four sub-scales identified in 
psychometric tests (somatic symptoms, anxiety and 
insomnia, social dysfunction and severe 
depression).17, 26 Likert scoring, items ranging from 
1-4.  
Case scoring, items ranging from 0-1.  
Range sum Likert scoring: 0-84, 
lower score indicates lower level 
of distress.  
Range sum Case scoring: 0-28, 
cutoff at 5; < 5 indicates normal 
mood, and ≥ 5 indicates low mood. 
T1, T2, T3 
Secondary 
outcomes 
Measure Description 
 
Assessment  
Health-related 
quality of life  
Stroke and Aphasia Quality 
of Life Scale-39 generic 
stroke version (SAQOL-
39g) 41, 42 
Self-report 39-item stroke-specific health-related 
quality of life scale. Measures patient’s perspective 
of stroke’s impact on ‘physical’, ‘psychosocial’ and 
‘communication’ domains. Likert scoring, items 
ranging from 1-5.  
Range mean score: 1-5 
Higher mean score indicates higher 
functioning; higher quality of life 
score. 
T1, T2, T3 
Sense of 
coherence  
Sense of Coherence scale 
(SOC-13) 28 
Self-report questionnaire, 13 items measuring the 
main concepts in the sense of coherence theory; 
coherence, meaningfulness and manageability. 
Likert scoring, ranging from 1–5.  
Sum range: 13-65.  
Higher scores indicate a stronger 
sense of coherence. 
T1, T2, T3 
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Depression  The Yale Brown single item 
questionnaire (Yale) 43, 44 
Self-reported presence or absence of depression.  Yes/No T1, T2, T3 
Characteristics 
of sample 
Measure Description 
 
Assessment  
Fatigue Fatigue Questionnaire-2 
(FQ-2) 45, 46 
Self-reported presence or absence of fatigue.  
If yes; indication of duration of symptoms.  
Yes/No 
 
T1, T2, T3 
Aphasia The Ullevaal Aphasia 
Screening Test (UAS) 47 
Screening for aphasia. Based on scores and clinical 
judgement, 4 categories: 1) No language impairment, 
2) Mild language impairment, 3) Moderate language 
impairment, 4) Severe language impairment. 
Range 0-52, scores <50 indicate 
pathologic language functioning.48 
T1 
Stroke severity/ 
neurological 
deficit 
National Institutes of Health 
Stroke Scale (NIHSS) 49 
An 11-item scale used by healthcare providers to 
objectively quantify the impairment caused by 
a stroke. 
Range 0-42.  
Cutoffs: 0-5=Mild symptoms of 
stroke, 6-10= moderate symptoms 
of stroke, ≥11=Moderate to severe 
stroke symptoms. 
T0 
Cognitive 
function 
Mini Mental State 
Evaluation (MMSE) 50 
30-point test that is used to measure potential 
cognitive impairment. 
Range 0-30.   
Cutoff at 24 to indicate cognitive 
impairment. A score below 24 
indicates cognitive impairment 
ranging from mild (19-23), 
moderate (10-18), and severe (≤ 9). 
T0 
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Table 2: Baseline demographics and clinical characteristics 
 
Intervention group 
(n=166) 
Control group 
(n=156) 
Baseline demographics   
Age, years, mean (SD) 66.8 (12.1) 65.7 (13.3) 
Sex   
 Female 67 (40.4) 65 (41.7) 
 Male 99 (59.6) 91 (58.3) 
Living conditions   
 Living with someone 117 (70.5) 101 (63.7) 
 Living alone 49 (29.5) 55 (35.3) 
Have caring responsibilities  37 (22.3) 36 (23.1) 
 Underage children 26 (15.7) 22 (14.1) 
 Spouse or cohabiting partner 10 (6.0) 6 (3.8) 
 Parents 2 (1.2) 6 (3.8) 
 Other 2 (1.2) 6 (3.8) 
Clinical characteristics   
Stroke classification (n=147; 144)    
 Infarction 128 (87.1) 136 (94.4) 
 Hemorrhage 19 (12.9) 8 (5.6) 
Stroke symptom localization (n=142; 136)   
  Right 65 (45.8) 56 (41.2) 
   Left 70 (49.3) 74 (54.4) 
  Bilateral 7 (4.9) 6 (4.4) 
Communication difficulties (n=121; 129) 44 (34.1) 42 (34.7) 
Feeling sad or depressed (Yale) 29 (17.5) 43 (27.6) 
Feeling fatigued (FQ-2) (n=165; 156) 88 (53.3) 87 (55.8) 
NIHSS, median (IQR) (n=126; 114) 4 (1-7) 2.5 (1-6) 
NIHSS categorized scores (n=126; 114)   
 Mild (0-5) 85 (67.5) 85 (74.6) 
 Moderate (6-10) 28 (22.2) 17 (14.9) 
 Moderate to severe (11+) 13 (10.3) 12 (10.5) 
MMSE, median (IQR) (n=63; 65) 27 (25-29) 28 (26-30) 
UAS (n=163;156) median (IQR) 52 (50-52) 52 (50-52) 
Receive one or more rehabilitation services at baseline 114 (68.7) 99 (63.5) 
 Physical therapy 98 (59.0) 88 (56.4) 
 Occupational therapy 73 (44.0) 62 (39.7) 
 Speech and language therapy 30 (18.1) 27 (17.3) 
 Home nursing care 56 (33.7) 46 (29.5) 
 Psychologist/psychiatrist 14 (8.4) 11 (7.1) 
 Other 22 (13.3) 14 (9.0) 
Comorbidities   
 No reported comorbidities 31 (18.7) 32 (20.5) 
 Hypertension 71 (42.8) 64 (41.0) 
 Heart disease 49 (29.5) 39 (25.0) 
 Diabetes 22 (13.3) 21 (13.5) 
 Stroke 22 (13.3) 25 (16.0) 
 Cancer 21 (12.7) 21 (13.5) 
 Musculoskeletal diseases 21 (12.7) 22 (14.1) 
 Rheumatic diseases  16 (9.6) 15 (9.6) 
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 Depression  13 (7.8) 16 (10.3) 
 Gastrointestinal diseases 12 (7.2) 11 (7.1) 
 Lung disease 8 (4.8) 10 (6,4) 
 Other reported comorbidities 16 (9.6) 15 (9.6) 
Values are n (%) unless stated otherwise. SD indicates standard deviation, IQR indicates interquartile range, 
NIHSS indicates National Institutes of Health Stroke Scale, MMSE indicates the Mini Mental State Exam. UAS 
indicates Ulleval Aphasia Screening. Comorbidities and rehabilitation services were self-reported by 
participants. Communication difficulties were self-reported and/or assessed in the acute phase and recorded in 
patient records.
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Table 3: Primary and secondary outcomes with between-group differences at 12-month follow up, by group 
 
T1=Baseline assessment at 4-6 weeks post-stroke, T2=Assessment at 6 months post-stroke immediately after intervention, T3=Assessment at 12 months post-stroke 
† Between group differences at T3. 
‡ Reporting pooled results of imputed data.  
‖ Logistic regression, (OR (95% CI)). 
** Independent samples t-test, (mean difference (95% CI)). 
*** Reporting pooled results of imputed data, new factor structure sum score. 
 
 
 Intervention group (n=166) Control group (n=156) 
Between group differences at 12 
months (T3) 
Outcomes T1  T2 T3 T1 T2  T3  P Value† 
GHQ-28 (<5)‡ (N (%)) 50 (30.1) 99 (59.6) 109 (65.7) 46 (29.5) 93 (59.6) 103 (66.0) 0.98 (0.62, 1.57) 0.946‖ 
GHQ-28 (sum, range: 0-84)‡ (Mean (SE)) 25.9 (0.84) 21.2 (0.83) 20.6 (0.84) 28.5 (0.98) 21.5 (0.89) 19.9 (0.85) -0.74 (-3.08, 1.60) 0.537** 
 Somatic symptoms2(Range: 0-9) (Mean (SE))*** 2.4 (0.18) 1.8 (0.17) 1.8 (0.15) 2.8 (0.20) 1.8 (0.17) 1.9 (0.15) 0.10 (-0.31, 0.52) 0.618** 
 Anxiety and insomnia (Range: 0-33) (Mean (SE))*** 8.3 (0.43) 7.1 (0.40) 7.3 (0.43) 9.0 (0.49) 7.4 (0.46) 7.0 (0.45) -0.30 (-1.55, 0.95) 0.634** 
 Social dysfunction (Range: 0-30) (Mean (SE))*** 14.8 (0.38) 11.5 (0.40) 10.8 (0.36) 15.7 (0.42) 11.4 (0.38) 10.4 (0.32) -0.36 (-1.32, 0.60) 0.457** 
 Severe depression (Range: 0-12) (Mean (SE))*** 0.5 (0.10) 0.7 (0.13) 0.8 (0.13) 0.9 (0.17) 0.9 (0.15) 0.6 (0.11) -0.18 (-0.52, 0.17) 0.314** 
Feeling sad or depressed (Yale) (N(%))‡ 29 (17.4) 37 (22.3) 38 (22.9) 43 (27.6) 36 (23.1) 37 (23.7) 0.96 (0.55, 1.68)   0.890‖ 
Sense of coherence (SOC-13, sum, range: 13-65)  
(Mean (SE))‡ 
50.6 (0.42) 50.2 (0.58) 50.6 (0.62) 50.4 (0.47) 50.5 (0.52) 51.0 (0.56) 0.43 (-1.09, 1.94) 0.581** 
Quality of Life (SAQOL-39g, mean, range: 1-5)  
(Mean (SE))‡ 
4.30 (0.04) 4.38 (0.05) 4.36 (0.04) 4.24 (0.05) 4.37 (0.04) 4.43 (0.04) 0.06 (-0.04, 0.17) 0.247** 
 Physical domain (Range: 1-5) (Mean (SE))‡ 4.24 (0.07) 4.52 (0.06) 4.50 (0.05) 4.21 (0.08) 4.52 (0.05) 4.57 (0.05) 0.06 (-0.07, 0.20) 0.364** 
 Communication domain (Range: 1-5) (Mean (SE))‡ 4.75 (0.04) 4.76 (0.03) 4.73 (0.04) 4.74 (0.05) 4.79 (0.03) 4.79 (0.04) 0.06 (-0.05, 0.16) 0.271** 
 Psychosocial domain (Range: 1-5) (Mean (SE))‡ 3.90 (0.06) 3.86 (0.07) 3.85 (0.07) 3.76 (0.06) 3.79 (0.08) 3.93 (0.07) 0.07 (-0.11, 0.25) 0.447** 
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Table 4: Linear mixed model showing fixed effect coefficients  
 
   95% CI  
 
Coefficient SE Lower Upper p-value 
Intercept 54.551 3.472 47.746 61.355 <0.001 
Time      
 Baseline (Ref.)      
 6-months post-stroke -5.648 0.560 -6.745 -4.551 <0.001 
 12-months post-stroke -6.490 0.588 -7.642 -5.338 <0.001 
Group allocation 
     
 Control Group (Ref.)      
 Intervention group -0.956 0.622 -2.175 0.264 0.125 
Sex      
 Female (Ref.)      
 Male 0.124 0.647 -1.145 1.393 0.848 
Age at admission -0.027 0.024 -0.073 0.019 0.249 
Stroke classification      
 Infarction (Ref.)      
 Hemorrhage 0.804 1.131 -1.414 3.021 0.477 
Stroke symptom localization      
 Right (Ref.)      
 Left 0.390 0.673 -0.940 1.719 0.563 
 Bilateral 1.433 2.022 -2.539 5.405 0.479 
Stroke severity (NIHSS) 0.117 0.097 -0.075 0.309 0.228 
Live with partner or other  -0.183 0.671 -1.499 1.133 0.785 
Comorbidity 1.792 0.716 0.388 3.196 0.012 
Rehabilitation Services 0.798 0.617 -0.410 2.007 0.195 
Caring responsibilities 2.599 0.873 0.889 4.309 0.003 
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Depression (Yale) 5.514 0.951 3.650 7.377 <0.001 
Fatigue (FQ-2) 4.091 0.644 2.829 5.352 <0.001 
Sense of coherence (SOC-13) -0.638 0.058 -0.753 -0.524 <0.001 
Dependent variable: GHQ-28, sum-score range from 0-84 (Likert scoring). N=322. 
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Figure 1: CONSORT participant recruitment and retention flow chart 
  
 
 
 
 
 
 
 
 
 
 
 
 
Excluded (n= 317) 
   Not meeting inclusion criteria (n= 63) 
   Declined to participate (n= 211) 
   Lost to competing studies (n= 12) 
   Other reasons (n= 31) 
Allocated to intervention (n= 166) 
 
Did not receive allocated intervention (n= 12) 
Reasons: 
  Due to group allocation (n=4) 
  Felt too healthy to participate (n=1) 
  Other medical condition (n=2) 
  Total burden of rehabilitation (n=1) 
  Unavailable after discharge (n=1)  
  Did not disclose reason (n=3) 
 
Received intervention (n= 154) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated to control (n= 156) 
 
 
 
 
Allocation 
Randomized (n= 322) 
Enrolment 
Eligible, gave consent (n= 353) 
Drop-out after initial consent (n= 31) 
  Missed data collection deadline (n= 8) 
  Unavailable after discharge (n= 5) 
  Other medical condition (n= 5) 
  Did not disclose reason (n= 5) 
  Death (n= 4) 
  Diagnosis change, not eligible (n= 2) 
  Felt overwhelmed (n= 1) 
  Felt too healthy to participate (n= 1) 
 
 
 
 
 
 
 
Assessed for eligibility (n= 670) 
Lost to follow up (n=11) 
  Other medical condition (n=6) 
  Total burden of rehabilitation (n=2) 
  Unavailable at time of follow-up (n=3)  
 
Follow-up (T2) 
6 months  
Lost to follow up (n=14) 
  Due to group allocation (n=2) 
  Other medical condition (n=3) 
  Unavailable at time of follow-up (n=5)  
  Did not wish to disclose reason (n=3) 
  Death (n=1) 
 
 
Follow-up (T3) 
12 months  
Lost to follow up (n=1) 
  Unavailable at time of follow-up (n=1) 
 
Lost to follow up (n=2) 
  Death (n=2) 
 
 
 
Baseline (T1) 
4-6 weeks  
Intention-to-treat analysis (n=166) 
Complete cases (n=142) 
Intention-to-treat analysis (n=156) 
Complete cases (n=140) 
 
Analysis 
